
A Dialysis Duopoly: How Public Funding Entrenched Private Power
For the half-million people in the U.S. with kidney failure, survival rests in the hands of two powerful corporations — DaVita and Fresenius — that control over 70% of the outpatient dialysis market. But the history of dialysis isn’t a simple narrative of corporate consolidation; it’s a case study of how public funding can entrench private power in health care.